Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 07, 2023

BUY
$45.44 - $74.26 $1,226 - $2,005
27 Added 0.37%
7,419 $487,000
Q4 2022

Jan 17, 2023

BUY
$41.39 - $81.0 $3,766 - $7,371
91 Added 1.25%
7,392 $333,000
Q3 2022

Oct 14, 2022

BUY
$72.36 - $113.1 $53,618 - $83,807
741 Added 11.3%
7,301 $528,000
Q2 2022

Jul 12, 2022

SELL
$87.2 - $114.05 $1,395 - $1,824
-16 Reduced 0.24%
6,560 $704,000
Q1 2022

Apr 07, 2022

BUY
$94.19 - $124.49 $57,079 - $75,440
606 Added 10.15%
6,576 $729,000
Q4 2021

Jan 13, 2022

BUY
$119.57 - $139.07 $79,753 - $92,759
667 Added 12.58%
5,970 $764,000
Q3 2021

Jan 13, 2022

SELL
$109.17 - $142.35 $23,144 - $30,178
-212 Reduced 3.84%
5,303 $706,000
Q2 2021

Jul 20, 2021

SELL
$100.34 - $115.69 $6,923 - $7,982
-69 Reduced 1.24%
5,515 $596,000
Q1 2021

May 10, 2021

SELL
$101.51 - $125.27 $12,282 - $15,157
-121 Reduced 2.12%
5,584 $588,000
Q4 2020

Jan 08, 2021

SELL
$85.88 - $105.36 $809,075 - $992,596
-9,421 Reduced 62.28%
5,705 $594,000
Q3 2020

Oct 15, 2020

SELL
$72.74 - $92.5 $405,816 - $516,057
-5,579 Reduced 26.95%
15,126 $1.3 Million
Q2 2020

Jul 07, 2020

BUY
$48.02 - $79.04 $171,671 - $282,568
3,575 Added 20.87%
20,705 $1.52 Million
Q1 2020

Apr 10, 2020

BUY
$36.95 - $62.95 $45,448 - $77,428
1,230 Added 7.74%
17,130 $890,000
Q4 2019

Jan 09, 2020

BUY
$47.06 - $56.64 $160,945 - $193,708
3,420 Added 27.4%
15,900 $895,000
Q2 2019

Jul 12, 2019

BUY
$39.26 - $54.21 $22,770 - $31,441
580 Added 4.87%
12,480 $677,000
Q3 2018

Nov 26, 2018

BUY
$40.12 - $45.55 $39,919 - $45,322
995 Added 9.12%
11,900 $542,000
Q1 2018

Jun 01, 2018

BUY
$39.4 - $47.39 $89,832 - $108,049
2,280 Added 26.43%
10,905 $448,000
Q4 2017

Jan 19, 2018

BUY
$37.27 - $43.02 $38,574 - $44,525
1,035 Added 13.64%
8,625 $354,000
Q3 2017

Oct 17, 2017

BUY
$33.75 - $41.67 $256,162 - $316,275
7,590
7,590 $303,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.